Myeloproliferative hypereosinophilic syndrome (Q107462): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/432743384
@@ Property / Canonical URI: https://id.who.int/icd/entity/432743384 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_432743384
@@ Property / CURIE: CID11:ID_432743384 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_432743384
@@ Property / Canary Token: dki-india-ID_432743384 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-16T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-16T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 16 August 2026 / rank @@
+Normal rank

Latest revision as of 14:27, 17 August 2026

These are a group of diseases of the bone marrow in which excess cells are produced. They are related to, and may evolve into, myelodysplastic syndrome and acute myeloid leukemia, although the myeloproliferative diseases on the whole have a much better prognosis than these conditions.

Language	Label	Description	Also known as
default for all languages	ID_432743384
English	Myeloproliferative hypereosinophilic syndrome	These are a group of diseases of the bone marrow in which excess cells are produced. They are related to, and may evolve into, myelodysplastic syndrome and acute myeloid leukemia, although the myeloproliferative diseases on the whole have a much better prognosis than these conditions.